The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical validation of Northstar Response, a novel methylated ctDNA therapy response monitoring assay in patients with advanced GI cancer undergoing active treatment.
 
Ilyas Sahin
No Relationships to Disclose
 
Doga Kahramangil
No Relationships to Disclose
 
Sherise C. Rogers
Consulting or Advisory Role - Natera
 
Brian Hemendra Ramnaraign
Consulting or Advisory Role - Cardinal Health; Ipsen; Merck; Pfizer
 
Pravalika Manda
Employment - UF Health Cancer Center
 
Matthew Gordon Varga
Employment - BillionToOne
 
Gary A. Palmer
Employment - BillionToOne
Leadership - BillionToOne
Stock and Other Ownership Interests - BillionToOne
 
Patrick Peiyong Ye
Employment - BillionToOne, Inc.
Stock and Other Ownership Interests - BillionToOne, Inc.
Patents, Royalties, Other Intellectual Property - molecular diagnostic patents pending with BillionToOne, Inc.
 
Thomas J. George
Consulting or Advisory Role - BillionToOne; Seagen; Tempus
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BillionToOne (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Elicio Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Ipsen (Inst); Jounce Therapeutics (Inst); Lilly (Inst); Merck (Inst); OncoC4 (Inst); Seagen (Inst)